NCT00003733View on ClinicalTrials.gov

Sequential Chemotherapy in Treating Patients With Residual Disease Following Surgery for Stage IIB, Stage III, or Stage IV Ovarian Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 1997

Conditions
Ovarian Cancer
Interventions
DRUG

carboplatin

DRUG

paclitaxel

DRUG

topotecan hydrochloride

Trial Locations (2)

W6 8RF

Charing Cross Hospital, London

HA6 2RN

Mount Vernon Hospital, Northwood

Sponsors

Lead Sponsor

SmithKline Beecham
All Listed Sponsors
lead

SmithKline Beecham

INDUSTRY